Managed Care Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cornell University
Anticoagulation therapy for antiphospholipid syndrome is subject of debate
August 16th, 2005
Antiphospholipid syndrome was the focus of a recent review. According to the review published in the Southern Medical Journal, "Antiphospholipid syndrome spans many medical disciplines. Classic criteria include the presence of anticardiolipin antibody or lupus anticoagulant with typical complications of thrombosis or pregnancy loss." L.R. Sammaritano of Cornell University continued, "Other common associated manifestations include livedo reticularis, thrombocytopenia, valvular heart disease, and nephropathy with renal insufficiency, hypertension, and proteinuria. Treatment of serious complications with anticoagulation is standard; generally...
Source: Managed Care Business Week (2005-08-16)
|
